Interested to hear from the value gurus please.
Amgen plans to buy Horizon Therapeutics for about $28 billion in cash, bringing on board two blockbuster drugs to ease the hit the biotech giant faces from biosimilar competition.
https://endpts["DOT"]com/amgen-to-buy-horizon-for-28b-in-the-years-biggest-pharma-takeover/
a) Does a deal like this offer any general value guidance IF MSB can deliver on it's lead programs?
b) Does this signal the big pharma sector is slipping into deal mode?
Interested to hear from the value gurus please. Amgen plans to...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |